<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01952626</url>
  </required_header>
  <id_info>
    <org_study_id>KNUH 2013-03-032-001</org_study_id>
    <nct_id>NCT01952626</nct_id>
  </id_info>
  <brief_title>Prevention of Intrathecal Morphine Induced Pruritus: Comparison of Ondansetron and Palonosetron</brief_title>
  <official_title>Prevention of Intrathecal Morphine Induced Pruritus: Comparison of Ondansetron and Palonosetron</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kyungpook National University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kyungpook National University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intrathecal administration of morphine is often used for control of postoperative pain.
      However, pruritus is one of the most common side effects of intrathecal morphine . Specific
      serotonin receptor antagonists could be an effective prophylactic treatment of neuraxial
      opioid-induced pruritus. It was reported that palonosetron is more effective than ondansetron
      for prevention of postoperative nausea and vomiting. Therefore, the investigators evaluated
      the efficacy of prophylactic administration of ondansetron and palonosetron for the
      prevention of intrathecal morphine-induced pruritus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intrathecal administration of morphine is often used for relief of postoperative pain.
      However, pruritus is one of the most common side effects associated with intrathecal
      morphine. Specific serotonin receptor antagonists such as ondansetron could be an effective
      prophylactic treatment of neuraxial opioid-induced pruritus. It was reported that
      palonosetron is more effective than ondansetron for prevention of postoperative nausea and
      vomiting. Therefore, the investigators evaluated the efficacy of prophylactic administration
      of ondansetron and palonosetron for the prevention of intrathecal morphine-induced pruritus.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of pruritus</measure>
    <time_frame>24 hours after spinal anesthesia</time_frame>
    <description>record of the incidence of pruritus after spinal anesthsia</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Morphine Adverse Reaction</condition>
  <arm_group>
    <arm_group_label>ondansetron</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous administration of ondansetron 4mg 15 minutes before spinal anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>palonosetron</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intravenous administration of palonosetron 0.075mg 15 minutes before spinal anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ondansetron</intervention_name>
    <description>intravenous injection</description>
    <arm_group_label>ondansetron</arm_group_label>
    <other_name>zofran</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Palonosetron</intervention_name>
    <description>intravenous injection</description>
    <arm_group_label>palonosetron</arm_group_label>
    <other_name>aloxi</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  19-70 years,

          -  American Society of Anesthesiology physical status 1 and 2

          -  Scheduled for elective urologic surgery under spinal anesthesia.

        Exclusion Criteria:

          -  Patients with cardiac and psychological problems.

          -  Patients who take sedatives or narcotics.

          -  Patient who have allergy to study drugs.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Younghoon Jeon, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kyungpook National University Hopsital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kyungpook National Hospital</name>
      <address>
        <city>Daegu</city>
        <zip>700-721</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 11, 2013</study_first_submitted>
  <study_first_submitted_qc>September 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2013</study_first_posted>
  <last_update_submitted>April 7, 2015</last_update_submitted>
  <last_update_submitted_qc>April 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kyungpook National University</investigator_affiliation>
    <investigator_full_name>Younghoon Jeon</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>intrathecal</keyword>
  <keyword>morphine</keyword>
  <keyword>ondansetron</keyword>
  <keyword>palonosetron</keyword>
  <keyword>pruritus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pruritus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Ondansetron</mesh_term>
    <mesh_term>Palonosetron</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

